We also analyzed the activity of the PI3K/Akt and Wnt/β-catenin pathways using CRC cell lines, HT-29 and HCT-116, treated with IGF1, Wnt3a, or both combined. The gene discussed is AKT1; the disease is colorectal carcinoma.